Association of pneumonia with ACEI and ARB dose | Download Table
NKF KDOQI Guidelines
Comparative Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Coronary Artery Bypass Grafting | Scientific Reports
Should ACE-inhibitors and ARBs be stopped with COVID-19? — NephJC
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING: TOOL ... | GrepMed
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy | NEJM
Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan | SpringerLink
Are angiotensin-blocking drugs being used in adequate doses? - The British Journal of Cardiology
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect
Calcium Channel Blocker Compared With Angiotensin Receptor Blocker for Patients With Hypertension: A Meta‐Analysis of Randomized Controlled Trials - Wu - 2014 - The Journal of Clinical Hypertension - Wiley Online Library
Effect of Fimasartan versus Valsartan and Olmesartan on Office and Amb | DDDT
PDF] UCLH GUIDELINES ON ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) FOR HYPERTENSION AND HEART FAILURE | Semantic Scholar
ACE Inhibition versus Angiotensin Receptor Blockade: Which Is Better for Renal and Cardiovascular Protection? | American Society of Nephrology